Cargando…
Recent Advances in Treatment of Primary Central Nervous System Lymphoma
Therapeutic options are limited in primary central nervous system lymphoma (PCNSL) with no uniform consensus on optimal management and few published, randomized trials. High-dose methotrexate in combination with other chemotherapeutic agents forms the mainstay of treatment. There hasn’t been much pr...
Autores principales: | Nayak, Lakshmi, Batchelor, Tracy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841579/ https://www.ncbi.nlm.nih.gov/pubmed/23934511 http://dx.doi.org/10.1007/s11864-013-0252-6 |
Ejemplares similares
-
The Role of Autophagy in Childhood Central Nervous System Tumors
por: Wang, Yafeng, et al.
Publicado: (2022) -
Current State of Immunotherapy for Treatment of Glioblastoma
por: McGranahan, Tresa, et al.
Publicado: (2019) -
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
por: Wong, Eric T, et al.
Publicado: (2015) -
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
por: Ghiaseddin, Ashley P., et al.
Publicado: (2020) -
Clinical Trial Considerations in Neuro-oncology
por: Lee, Eudocia Q.
Publicado: (2021)